Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 1,441 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Measurement Clear all

Conditions: Vital Sign Evaluation
Interventions: SmartSpectra Vital Signs Monitor measurement; Device
Lead sponsor: Presage Technologies, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Healthy
Interventions: Pulse Oximeter sensor; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 2
States / cities: Irvine, California • Loma Linda, California

Conditions: Measure Accuracy of Respiratory Rate
Interventions: Respiratory rate measure based on PPG; Device
Lead sponsor: Gabi SmartCare; Industry
Eligibility: 1 Minute to 12 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Diabetes Mellitus
Interventions: case management with telemonitoring, usual case management; Behavioral
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 460 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Lobectomy, Segmentectomy, Force Measurement
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Substance Use Disorder (SUD)
Interventions: none, there is no intervention in this study; Other
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Food Hypersensitivity
Interventions: Not listed
Lead sponsor: ORA, Inc.; Industry
Eligibility: 5 Years to 35 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anesthesia, Pregnancy Related, Blockades Neuromuscular
Interventions: ClearSight; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 327 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Congenital Heart Disease
Interventions: SpO2/PIx Measurement and ML Algorithm; Diagnostic Test
Lead sponsor: University of California, Davis; Other
Eligibility: 0 Minutes to 21 Days
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Davis, California • Queens, New York • Salt Lake City, Utah

Conditions: Dysmenorrhea, Heavy Menstrual Bleeding, Contraception
Interventions: Transabdominal Ultrasound; Diagnostic Test
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 12 Years to 22 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Anxiety Disorders
Interventions: lorazepam, placebo, paroxetine; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 169 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 15
States / cities: Glendale, California • Northridge, California • Orange, California + 10 more

Conditions: Peripheral Arterial Disease
Interventions: BLOOD PRESSURE MEASURMENT, BLOOD PRESSURE MEASUREMENT; Procedure
Lead sponsor: Summit Doppler Systems, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Tobacco Dependence
Interventions: Nicotine Spray, Placebo; Drug
Lead sponsor: McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 1,198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 8
States / cities: Scottsdale, Arizona • Burbank, California • Chicago, Illinois + 5 more

Conditions: Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal Tandem Duplication, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Interventions: Azacitidine, Laboratory Biomarker Analysis, Nintedanib; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Corneal Endothelial Cell Loss
Interventions: Specular Microscope Nidek CEM-530, Specular Microscope Konan CELLCHEK XL; Device
Lead sponsor: Nidek Co. LTD.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Myopathy, Muscular Dystrophies, Myositis, Myofibrillar Myopathy, Congenital Myopathy, Distal Myopathy, Myopathies
Interventions: Electrical Impedance Myography; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Arterial Ischemic Stroke
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years to 18 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Malignant Solid Neoplasm, Hematopoietic Neoplasms, Lymphatic System Neoplasm
Interventions: Surveys/Questionnaires; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 15 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Congestive Heart Failure
Interventions: CoVa; Device
Lead sponsor: Aventyn, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction
Interventions: fMRI, Montreal Cognitive Assessment (MoCA), Digital Clock Drawing Test Command and Copy, Wide Range Achievement Test reading subtest, Hopkins Verbal Learning Test (HVLT), General Depression Scale (GDS); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 99 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Healthy Subjects
Interventions: Trans-Sodium Crocetinate, Placebo; Drug
Lead sponsor: Diffusion Pharmaceuticals Inc; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Lactation, Inflammatory Bowel Disease
Interventions: Mirikizumab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 3 Weeks and older · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Glenview, Illinois • Iowa City, Iowa • Baltimore, Maryland + 2 more

Conditions: Pregnant, Postpartum
Interventions: Point of care device to measure HbA1c; Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Diabetes, Hemodialysis, Glucose Measurement
Interventions: Dexcom G6 Continuous Glucose Monitor; Device
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Orange, California

Search by objective public record fields.

Clinical Validation of Non-Contact Vital Signs

Accuracy of Hemoglobin Measurement for Various Rainbow Pulse Oximeter Sensors

Respiratory Rate Validation Study

Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes

Evaluating the Association of Force Feedback With Outcomes After Lung Resection Using the da Vinci Multiport System

Identifying Substance Use Consequences

Food Allergy Challenge Diagnostic Study

Upper vs Lower Extremity BP in Spinal Cesarean Using ClearSight

Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements

Ultrasound Evaluation Versus Direct Measurement of Uterine Cavity Length

Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder

Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures

Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality

Muscle Health Measurements Using Electrical Impedance Myography

Optical Measurement of Cerebral Hemodynamics in Children With Acute Arterial Ischemic Stroke

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Assess Measurements of Wireless Cardiac Output Device

fMRI Connectivity in Fracture Hip Patients

Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers

A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c

Dexcom G6 Continuous Glucose Monitoring in Hemodialysis